R

Active Director Director DIN 09101773
DIN 09101773 First appointment Mar 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Rajmohan

Data last updated:

Rajmohan is a Director at Kalaxy Therapeuticals Private Limited (since 2021). The company operates in Chemicals. Kalaxy Therapeuticals Private Limited reported revenue of ₹3.4 Lakh (FY 2022).

DIN 09101773
Primary Designation Director
Industry Chemicals
First Appointment 11 Mar 2021
Oldest Company Age 5 yrs
Largest company Kalaxy Therapeuticals Private Limited · ₹3.4 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Mar 20212021₹3.4 Lakh (FY 2022)Active

Board colleagues of Rajmohan

Directorship timeline

Open interactive timeline →
Kalaxy Therapeuticals Private Limited
Premium access

Shareholding and investment profile for Rajmohan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajmohan

Rajmohan currently holds 1 directorship: Kalaxy Therapeuticals Private Limited (Director, since 11 Mar 2021, revenue ₹3.4 Lakh (FY 2022)).

Rajmohan was first appointed on 11 Mar 2021 as Director at Kalaxy Therapeuticals Private Limited.

The current boards of Rajmohan's companies include Ezhumalai Saravanan (Kalaxy Therapeuticals Private Limited), Neminathan Mugundhan (Kalaxy Therapeuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available